ESC 365 - Impact of Pirfenidone on arrhythmic and clinical outcomes in patients with idiopathic pulmonary fibrosis

ESC Professional Premium Access

Impact of Pirfenidone on arrhythmic and clinical outcomes in patients with idiopathic pulmonary fibrosis

Session: From cellular mechanisms to arrhythmias in non-cardiac diseases

Topic: Prevention

Speaker: Doctor S. Im (Pusan, KR)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Sung Il Im

kosin university gospel hospital, Pusan (Korea (Republic of))

0 follower

6 more presentations in this session

Arrhythmogenic effects of DEHP exposure: insights into cardiac electrophysiology and myocardial cells

Speaker: Doctor T. Lin (Taipei, TW)

Mitochondrial Oxidative Stress and Cardiac Dysfunction in TERT Knockout Mice

Speaker: Professor T. Liu (Tianjin, CN)

The Mutscore metapredictor: a new application of artificial intelligence in cardiogenetics

Speaker: Doctor A. Porretta (Lausanne, CH)

Comprehensive risk factor analysis for sick sinus syndrome: an analysis of genetic, sociodemographic, clinical and laboratory data from the UK Biobank.

Speaker: Doctor H. Kim (Daegu, KR)

Impact of SLGT2 inhibitors treatment initiation on the reduction of atrial and ventricular arrhythmias in patients with implanted cardiac defibrillator

Speaker: Doctor J. Gonzalez Juanatey (Santiago de Compostela, ES)

Access the full session

From cellular mechanisms to arrhythmias in non-cardiac diseases

Speakers: Doctor S. Im, Doctor T. Lin, Professor T. Liu, Doctor A. Porretta, Doctor H. Kim...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources